Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
H-8 . dihydrochloride
50
CHF
CHF 50.00
In stock
AG-CR1-0001-M01010 mgCHF 50.00
AG-CR1-0001-M05050 mgCHF 190.00
Product Details | |
---|---|
Synonyms | N-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide . 2HCl |
Product Type | Chemical |
Properties | |
Formula |
C12H15N3O2S . 2HCl |
MW | 265.3 . 72.9 |
CAS | 113276-94-1 |
Purity Chemicals | ≥98% (NMR) |
Appearance | White to off-white solid. |
Solubility | Soluble in DMSO or 100% ethanol (slightly soluble). |
InChi Key | RJJLZYZEVNCZIW-UHFFFAOYSA-N |
Smiles | [Cl-].[Cl-].C[NH2+]CC[NH2+]S(=O)(=O)C1=CC=CC2=CN=CC=C12 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Potent cAMP- and cGMP-dependent protein kinase (PKA and PKG) inhibitor [1, 2, 4].
- Myosin light chain kinase (MLCK) inhibitor [3].
- Tool to study protein crystal structure-inhibitor interactions [5].
Product References
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C: H. Hidaka, et al.; Biochemistry 23, 5036 (1984)
- Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors: M. Inagaki, et al.; Mol. Pharmacol. 29, 577 (1986)
- Specific binding of a novel compound, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H-8) to the active site of cAMP-dependent protein kinase: M. Hagiwara, et al.; Mol. Pharmacol. 31, 523 (1987)
- Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives: M. Hagiwara, et al.; Mol. Pharmacol. 32, 7 (1987)
- Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity: R.A. Engh, et al.; J. Biol. Chem. 271, 26157 (1996)